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ABSTRACT 
 
Autism is a complex neurodevelopmental disorder with a significant genetic component. 
The prevalence of autism has been increasing globally, though exact statistics for India 
are not available. Several genetic markers for autism have been studied. These include 
chromosomal  abnormalities,  copy  number  variations,  submicroscopic  cytogenetic 
anomalies, single nucleotide polymorphisms and other point mutations. This review gives 
details on the current data available on these genetic markers of autism, with a focus on 
single  nucleotide  polymorphisms.  Studies  on  SNPs  within  candidate  genes  on  each 
chromosome are dealt with, including some details on which populations show which 
variation. Methodology involved in analysis of SNPs, i.e. techniques in SNP genotyping 
are  also  reviewed,  focusing  on  those  techniques  that  are  simple  and  economically 
feasible in the Indian scenario.  
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INTRODUCTION 
 
Autism  is  a  complex,  behaviorally  defined, 
static  disorder  of  the  juvenile  brain  (age  of 
onset is 18  24 months 
[1]) that falls under the 
category  of  Autism  Spectrum  Disorders   a 
group  of  neurodevelopmental  disorders  with  
impairments  in  social  interaction, 
communication,  and  restricted  repetitive 
patterns of behavior and interests  that include 
Aspergers’s syndrome, disintegrative disorder, 
Rett  syndrome  and  PDD NOS  (pervasive 
developmental  disorder   not  otherwise 
specified). These are multifactorial (except Rett 
syndrome,  which  is  a  single  gene  disorder). 
The  prevalence  of  autism  has  been  rising 
globally  mainly  due  to  better  diagnostics.  2 
million people are estimated to have autism in 
India,  although  detailed  statistics  are  not 
available. 
[2, 3, 4, 5] Based on cause, autism can 
be  classified  into  idiopathic  (90%  cases,  with 
cause  unknown)  and  secondary  (genetic  or 
environmental  cause).  Genetic  causes  have 
been  found  to  play  a  major  role  (as 
demonstrated by concordance studies in twins 
and  siblings),  but  environmental  factors  like 
toxins,  teratogens,  prenatal  infections  and 
injuries are also causative. 
[6,  7, 
8, 
9, 
10,  11,  12]. 
This  review  deals  with  on  the  various  known 
genetic  markers  of  autism  and  the  methods 
available to genotype SNPs. 
 
GENETIC MARKERS 
Chromosomal Abnormalities 
Standard karyotyping procedures have shown 
chromosomal  abnormalities  in  some  autistic 
individuals. However, in most of these studies, 
sample  selection  did  not  follow  strict 
guidelines. 
[7] 
3.25 % of autistic individuals have unbalanced 
translocations,  inversions,  rings,  interstitial 
deletions, duplications etc. The most prevalent 
is  duplication  in  chromosome  15q11 13, 
usually  maternally  inherited.  Other  frequent 
findings  are  deletions  in  2q37,  7q31  and 
deletions or duplications of 22q13.  Klinefelter’s 
Syndrome (XXY), duplications of the Williams–
Beuren–Syndrome  region  7q11.23  and 
deletions  of  22q11  (Velo cardio facial 
Syndrome) are also associated with increased 
autistic phenotypic traits. 
[7] 
 
Copy number variations (CNVs) 
Some  CNVs  are  more  frequent  in  autism 
patients  than  in  controls.  Replicated  CNVs 
from genome wide association studies (GWAS) 
are located on  1q21, 2p16.3 (NRXN1), 3p25 
26  (CNTN4),  7q36.2  (DPP6),  15q11 13 
(UBE3A, OR4M2, OR4N4), 16p11.2 (MAPK3, 
MAZ,  DOC2A,  SEZ6L2,  HIRIP3,  IL6)  and 
22q11.2. 
[7]  A  study  using  SNP  arrays  in  the 
Netherlands shows that CNV of microcephalin 
1  gene  (MCPH1)  in  the  8p23.1  region  can 
occur  in  some  patients. 
[13]  However,  CNVs 
found in autistic individuals are not exclusively 
observed in autism  they also occur in patients 
of other neurological disorders. 
[7] 
 
Single nucleotide polymorphisms 
In  the  following  overview,  a  summary  of  the 
SNP  analysis  in  autism  till  date  based  on  a 
literature search is presented. The genes that 
have been studied are tabulated and details on 
SNPs follow. 
 
 
 
 Int J Pharm Bio Sci 2013 Jan; 4(1): (B) 31 - 41 
 
This article can be downloaded from www.ijpbs.net 
B - 33 
 
Table 1 
Genes studied for association with autism 
[14] 
 
Chromosome  Genes studied 
1  MTHFR, SFN, MTF1, RIMS3, DAB1, PDE4B, CYR61, DPYD, GSTM1, NGF, NOTCH2, RIT1, 
NTRK1, IFI16, ATP1A2, HSPA6, RFWD2, PTGS2, CHI3L1, MARK1, DISC1 
2  SNTG2,  NRXN1,  RAB11FIPS,  NPAS2,  DPP10,  CNTNAP5,  SCN2A,  SCN1A,  SCN7A, 
SLC25A12, DLX1, DLX2, RAPGEF4, HOXD11, ITGA4, INPP1, NRP2, PAX3 and CENTG2 
3  CNTN4,  OXTR,  GPX1,  CNTN3,  ROBO1,  ROBO2,  DRD3,  FBXO40,  FXR1,  PAK2,  DLG1, 
MBD4, SLC9A9, NLGN1, HTR3C and BCL6 
4  DRD5, CD38, SPP1, EIF4E, EGF, PCDH10 and TDO2 
5  SEMA5A, CDH10, CDH9, PRLR, DHFR, APC, PITX1, ADRB2, DRD1 and NSD1 
6  HLADRB1, PRL, C4B, SYNGAP1, RNF8, GLO1, HTR1B, GluR6, AH11 and PARK2 
7  HOXA1,  PON1,  DLX6,  DLX5,  TAC1,  NPTX2,  SERPINE1,  RELN,  PIK3CG,  NRCAM, 
IMMP2L, DOCK4, FOXP2, MET, FAM4A1, WNT2, CADPS2, UBE2H, NOBOX, CNTNAP2, 
DPP6 and EN2 
8  DLGAP2, MCPH1, SLC18A1, CSMD3, EXT1 and CYP11B1 
9  SLC1A1, ASTN2, TSC1 and DBH 
10  GATA3, EGR2, TRIP8, REEP3, KCNMA1 and PTEN 
11  IFITM3,  HRAS,  SCT,  PTCHD1,  BDNF,  PAX6,  SHANK2,  DHCR7,  SERPINH1,  MTNR1B, 
PTS, HTR3A, CADM1, ROBO3 and ROBO4 
12  AVPR1A, TPH2, IGF1, RFX4, DAO and HSPB8 
13  NBEA, HTR2A, DIAPH3 and PCDH9 
14  MDGA2 
15  TUBGCP5,  CYFIP1,  NIPA2,  NIPA1,  NDN,  SNRPN,  UBE2A,  ATP10C,  ATP10A,  GABRB3 
and RORA 
16  CACNA1H, TSC2, A2BP1, ABAT, GRIN2A, PRKCB1, SEZ6L2, SLC7A5 and ANKRD11 
17  PER1, PAI1, MAP2K3, NOS2A, SLC6A4, NF1, ITGB3, HOXB1, CACNA1G, BZRAP1 and 
PTDSR 
18  MBD1 and BCL2 
19  MBD3, GADD45B, TLE6, PDE4A, PLAUR, DMPK and SHANK1 
20  OXT and ADA 
22  DGCR6, PRODH, TBX1, COMT, MIF, ADORA2A, ADSL and SHANK3 
X  ASMT,  NLGN4,  STS,  APIS2,  GRPR,  CDKL5,  PTCHD1,  ARX,  AL1RAPL1,  DMD,  MAOA, 
JARID1C, UPF3B, HOPA, NLGN3, SLC9A6, FMR1, SLC6A8, IRAK1, MECP2, RPL10 and 
RAB39B 
Y  ASMT, NLGN4Y 
 
Chromosome 1 
This  chromosome  contains  a  susceptibility 
locus,  1q41 42.  Several  SNPs  in  the  MARK1 
gene  within  this  locus  are  associated  with 
autism, especially rs12740310, rs3737296 and 
rs12410279.  rs12410279  affects  the  level  of 
MARK1  gene  expression,  thus  affecting 
microtubule  dependent  transport,  dendritic 
transport speed and length. 
[15] 
Hemizygous  deletions  in  DYPD  gene  on 
1p21.3, along with additional mutation in other 
genes, can lead to autism. 
[16] 
Chromosome 2 
AUS5 (autism susceptibility 5) region is located 
on this chromosome. Different common SNPs 
in the mitochondrial aspartate/glutamate carrier 
(SLC25A12) gene on 2q24 are associated with 
autism. 
[7] 2p15 16.1 contains genes XPO1 and 
OTX1  in  which  rs6735330,  rs2018650  and 
rs13000344  are  associated  with  autism. 
However,  these  polymorphisms  are  not 
common variants among patients of idiopathic 
autism  and  thus  contribute  in  only  the  rare 
cases of 2p15 16.1 deletions. 
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the gene ITGA4, in which SNPs in exons 16 
and 17 are associated with autism. 
[18] Sodium 
channel genes SCN1A and SCN2A have SNPs 
in  coding  exons  and  splice  sites  in  autism 
patients.  Variant  R1902C  in  SCN2A  reduces 
the  channel’s  affinity  for  calcium bound 
calmodulin.  38  SNPs  have  been  reported  in 
these genes that need further analysis. 
[19] 
 
Chromosome 3 
Oxytocin  plays  a  role  in  social  cognition  and 
behavior  and  the  oxytocin  receptor  gene 
(OXTR) is linked with susceptibility to autism. 
Several SNP alleles of OXTR occur in autism. 
[7]  3q29  contains  20  genes  (including  PAK2, 
DLG1, FBX045). Microdeletion of 1.6  2.1 Mb 
is  associated  with  autism.  No  SNP  analysis 
studies  have  been  conducted  on  this. 
[20]  70 
SNPs in 3q25 27 have been studied by linkage 
analysis,  especially  those  in  FXR1  gene,  but 
none  contributed  to  autism  in  the  population 
studied. 
[21] 
 
Chromosome 5 
5p15  has  an  SNP  between  SEMA5A  and 
TAS2R1 genes which has been implicated in 
autism. 
[22] 6 SNPs have been found in 5p14.1, 
between  CDH10  and  CDH9  (both  of  which 
encode  neural  cell  adhesion  molecules),  of 
which rs4307059 is the most significant. 
[23] The 
region  5q31,  containing  the  PITX1  gene  has 
also  been  shown  to  have  polymorphisms 
present in autistic individuals. 
[24] 
 
Chromosome 6 
3 studies have shown association of different 
SNPs  in  the  Glutamate  receptor  6  (GluR6) 
genes. 
[7] 
 
Chromosome 7 
Most genes assessed in autism are located on 
7q22 36  (AUS1  region). 
[7]  Three  studies 
support  the  involvement  of  a  trinucleotide 
repeat  polymorphism  in  the  5′UTR  region  in 
RELN  gene  in  autism,  whereas  five  other 
similar  studies  do  not. 
[7]  Different,  possibly 
functional  variants  in  LAMB1  have  been 
associated with autism in two studies. LAMB1’s  
protein  promotes  neuronal  migration  and 
neurite outgrowth during development. 
[7] Two 
SNPs  in  the  Engrailed  2  (EN2) gene,  a 
homeobox  transcription  factor  on  7q36, 
involved in the development of brainstem and 
cerebellum,  are  associated  with  autism  in 
several  cases. 
[7]  Common  and  also  rare 
variants in the contactin associated protein like 
2 (CNTNAP2), a member of the neurexin super 
family can also increase the risk for autism in 
certain  cases.  CNTNAP2  plays  a  role  in  the 
language  circuitry,  thus  being  implicated  in 
autism. 
[7] The gene encoding the MET receptor 
tyrosine  kinase  is  involved  in  brain 
development and gastrointestinal repair. Since 
some  autistic  individuals  concurrently  suffer 
from  gastrointestinal  symptoms,  a  SNP 
genotyping of this gene has been conducted. A 
functional  promotor  variant,  several  other 
SNPs  as  well  as  rare  mutations  have  been 
found to be associated with autism in several 
samples. 
[7] 
 
Chromosome 8 In MCPH1, CNVs have been 
found as mentioned earlier. 
[14] 
 
Chromosome 10  
PTEN (phosphatase and tensin homologue, on 
10q23.3) is a tumour suppressor gene which is 
a  negative  regulator  in  the  PI3K  pathway. 
Heterozygous  PTEN  mutations  have  been 
found in some autistic individuals, resulting in 
low PTEN levels. 
[7] 
 
Chromosome 11  
In a Korean study, 2 SNPs – rs11212733 and 
rs7125479  have  been  found  that  could  be 
associated  with  autism 
[25]  while  in  a  Finnish 
population,  11p12 p13  region  (containing 
glutamate  transporter  genes)’s  SNPs  have 
been found to have no significant association 
with autism 
[26]. 
 
Chromosome 12 
 No  SNPs  from  this  chromosome  have  been 
implicated  in  autism,  but  submicroscopic 
chromosomal anomalies have been found. 
[14] 
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Chromosome 15 
Several  variants  of  genes  on  15q11 13  have 
been  assessed,  as  cytogenetic  abnormalities 
of  this  region  are  observed  in  autism,  but 
ATP10C, UBE3A and the gamma aminobutyric 
acid  (GABA)  receptor  genes  located  on  15q 
have given inconclusive findings. 
[7] 
 
Chromosome 17 
 Due to presence of platelet hyperserotonemia 
in  autistic  children  and  their  first degree 
relatives,  common  polymorphisms  in  the 
serotonin transporter  gene  (SLC6A4)  have 
been assessed in several studies. 
[7] 
 
Chromosome 22 
Several  case  reports  indicate  22q13.3 
deletions  and  duplications  as  risk  factors  for 
autism. SHANK3 gene, located in this region, 
encoding  a  synaptic  scaffolding  protein,  has 
been  assessed  for  SNPs  possibly  associated 
with autism. Several studies have shown both 
sporadic and inherited mutations in this gene in 
autistic  individuals.  Similar  to mutations of X 
chromosomal genes, SHANK3 mutations might 
cause  a  monogenic  form  of  language  delay. 
The  frequency  of  SHANK3  mutations  is  0.5–
1%  in  autistic  individuals.  Common  variants 
have  not  been  detected  as  risk  factors.  A 
recent  study,  however,  reported  SHANK3 
deletions in healthy individuals, implying that it 
might be a harmless polymorphism. 
[7] 
 
X-chromosome 
Keeping  in  mind  the  skewed  sex  distribution 
ratio in autism (males affected four times more 
than females), several variants in genes on X 
chromosome  have  been  analyzed  for 
association with autism. Two neuroligin genes  
NLGN2  and  NLGN4,  involved  in  synapse 
formation,  on  Xq13  and  Xp22  have  been 
screened for mutations. Despite the discovery 
of several non conservative mutations in single 
families in these genes, the findings could not 
be replicated in larger samples sizes. Similarly, 
two  mutations  identified  in  the  ribosomal 
protein  gene  RPL10  on  Xq28  could  not  be 
replicated in a later study. 
[7] 
 
Y-chromosome 
Few  studies  have  looked  into  association 
between  variants  on  the  Y  chromosome  and 
autism. A recent study has reported negligible 
association between an SNP in NLGN4Y gene, 
which  had  earlier  been  thought  to  be 
associated with autism. Hence, no SNPs on Y 
chromosome  have  been  associated  with 
autism. 
[7] 
 
METHOLOGY OF SNP ANALYSIS 
 
In silico methods 
Computational  SNP  analysis  is  the  most 
convenient and rapid method of SNP analysis 
but being theoretical, it can merely be used for 
prediction.  Still,  the  advent  of  SNP  analysis 
software  has  made  SNP  genotyping  much 
simpler now than it was a decade ago, helping 
to minimize the amount of experimental work 
and cost. The list of SNPs in a particular gene 
can  be  obtained  from  several  databases  
dbSNP  of  NCBI,  HapMart  of  HaploView  and 
HGMD  (Human  Gene  Mutation  Database) 
[27, 
47]. Analysis of these SNPs in order to prioritize 
them in terms of risk potential can be done by 
numerous tools that are either downloadable or 
available online. SIFT  Sorting Intolerant From 
Tolerant  It is a tool developed by the J Craig 
Venter  Institute  that  assigns  risk  potential  to 
non synonymous SNPs (nsSNP) based on the 
type  of  amino  acid  change  that  is  occurring. 
For  example,  a  change  from  a  positively 
charged  amino  acid  to  another  positively 
charged amino acid will not be considered risky 
whereas  a  change  from  polar  to  non polar 
amino acid will be considered very risky. 
[28  33] 
PolyPhen  Polymorphism Phenotyping  It uses 
physical  and  evolutionary  comparative 
considerations  to  predict  whether  the  amino 
acid  change  due  to  a  nsSNP  will  affect  the 
structure  and  function  of  human  proteins. 
[34] 
PANTHER   Protein  Analysis  Through 
Evolutionary  Relationships   The  cSNP  tool  of 
PANTHER  is  based  on  alignment  of 
evolutionarily  similar  sequences  in  order  to 
predict which among a set of non synonymous 
SNPs is likely to have deleterious functional  
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effect on the encoded protein. 
[35, 36, 37] 
FASTSNP   It  is  based  on  hidden 
Markov  models  and  prioritizes  SNPs  from 
“Very  low  risk”  to  “Very  high  risk”  based  on 
twelve phenotypic risks and putative functional 
effects. 
[38]  Pupasuite   is  an  interactive  web 
based tool selects relevant SNPs within a gene 
based on characteristics of the SNP (validation 
status,  type,  frequency/population  data  and 
putative functional properties). It also performs 
LD plotting on genotype data from HapMap. 
[39 ] 
SNPStats   Its  a  software  package  for  the 
analysis  of  genetic epidemiology  studies  of 
association  using  SNPs.  It  can  be  used  for 
arriving  at   allele  and  genotype  frequencies, 
test  for  Hardy Weinberg  equilibrium,  and 
analysis  of  association  with  a  response 
variable based on linear or logistic regression, 
multiple  inheritance  models  and  analysis  of 
interactions.  For  multiple  SNPs  linkage 
disequilibrium estimation, haplotype frequency 
estimation,  analysis  of  association  of 
haplotypes with the response and analysis of 
interactions  (haplotypes covariate)  can  be 
performed. 
[40]  Linkage  disequilibrium   Usually 
during  SNP  analysis,  a  large  set  of  SNPs 
needs  to  be  analyzed.  LD  plotting  helps  to 
reduce  this  number  to  only  those  SNPs  that 
are  closely  associated  with  the  gene  of 
interest.  Several  tools  are  available  for  this  
WGAViewer, SNPStats, HaploView and SNP & 
Variation Suite by Golden Helix. 
[27, 41] Genome 
browsing  Genome browser tools like Ensembl 
and UCSC Genome Browser can be used to 
determine  the  location  of  the  SNP  to  be 
analyzed  on  the  chromosome.  They  can  be 
used to determine whether the SNP falls within 
a  protein  coding  region,  promoter  sequence, 
untranslated region, intronic sequence etc. 
[42, 
43]There  are  numerous  other  tools  and 
databases for computational analysis of SNPs, 
with  specific  uses,  advantages  and 
disadvantages. 
 
Experimental methods 
RFLP   This  technique  is  based  on  the 
sequence  specificity  of  restriction 
endonucleases.  If  a  polymorphism  is  present 
within  this  sequence  for  a  particular  sample, 
the  enzyme  will  not  cleave  it,  resulting  in  an 
agarose  gel  electrophoresis  band  pattern 
different  from  the  expected  pattern.  Thus, 
genotyping can be easily achieved. 
[44] ARMS 
PCR (ARMS= amplification refractory mutation 
system)     This  method  detects  known  point 
mutations. An ARMS PCR experiment consists 
of two reactions  one containing a normal DNA 
sequence specific ARMS primer and the other 
containing  a  mutant specific  primer.  The 
genotype  is  determined  by  analysis  of  the 
amplification products: for homozygous normal 
individual, amplification occurs only for the first 
reaction,  for  homozygous  mutant  individual, 
amplification occurs only in the second reaction 
and for heterozygous individuals, reaction will 
occur in both. 
[46] A comparative study shows 
that ARMS PCR is better. ARMS PCR method 
involves  a  single  step  PCR.  Instead,  RFLP 
PCR  method  is  laborious,  needing  more 
optimization  steps,  reagents  and  human 
handling. 
[44]  ARMS PCR  is  suitable  for 
analysis  of  large  number  of  samples,  a 
situation which occurs often in SNP analysis. 
[44] Allelic discrimination real time PCR  It uses 
the  5’   3’  nuclease  activity  of  AmpliTaq  Gold 
DNA  polymerase.  By  PCR,  a  fluorescent 
reporter  probe  attached  to  the  DNA  is 
released,  allowing  direct  detection  of  PCR 
product. 
[45] Two TaqMan probes are used, one 
for  each  allele  in  a  two allele  system.  Each 
probe is made of an oligonucleotide with a 5´ 
reporter dye and a 3´ quencher dye. Differently 
coloured  reporter  dyes  are  used  for  the  two 
alleles. 
[45]  When  the  probe  is  intact,  the 
quencher  dye  quenches  the  reporter  dye’s 
fluorescence.  During  PCR,  forward  and 
reverse  primers  hybridize  to  a  specific 
sequence  of  the  target  DNA.  The  probe 
hybridizes to a target sequence within the PCR 
product. The enzyme cleaves the probe with its 
5´–3´ nuclease activity as it moves along the 
strand.  Thus,  the  reporter  dye  and  quencher 
dye are separated, resulting in fluorescence of 
the reporter. The 3´ end of the probe is blocked 
to prevent extension of the probe during PCR. 
[45] 
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Figure 1 
Principle of allelic discrimination real time PCR 
45 
 
 
 
This  process  occurs  in  every  cycle,  without  affecting  the  exponential  product  accumulation.  The 
separation of the reporter dyes from the quencher dye results in increase in fluorescence for each 
of the reporters, which is due to target amplification during PCR.
 [45] 
 
Figure 2 
Representative output of allelic discrimination real time PCR 
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Red  fluorescence  implies  homozygosity  for 
allele 1, blue implies homozygosity for allele 2 
and  green  implies  heterozygosity. 
[45]  Both 
primer  and  probe  must  hybridize  to  their 
targets for amplification and cleavage to occur. 
The fluorescence signals are generated only if 
the  target  sequences  for  the  probes  are 
amplified  during  PCR.  Because  of  this,  non 
specific  amplification  is  not  detected. 
[45] 
Sequencing   Direct  sequencing  of  DNA  by 
chain  termination  method  is  usually  the  final 
step  in  SNP  genotyping.  Earlier  methods 
involved autoradiography and 4 reaction tubes. 
The  advent  of  automated  sequencers  has 
simplified  this  to  a  single  reaction  tube  and 
automated  capillary  electrophoresis. With  this 
method,  96  samples  can  be  sequenced  at  a 
time.  However,  for  the  large  number  of 
samples  used  nowadays,  even  this  is  not 
sufficient. This has led to the development of 
next generation  high throughput  sequencing 
technology.    This  is  particularly  useful  for 
genotyping applications since only a small  
fragment has to be sequenced. One of these 
methods is pyrosequencing. This is based on 
transformation of the pyrophosphate molecules 
released during DNA elongation into light (the 
reaction  being  PPi  to  ATP  which  in  turn  is 
utilized  by  luciferase  to  emit  light).  Hence,  a 
real  time  quantitative  determination  of 
nucleotide  incorporation  is  possible. 
Pyrosequencing  has  been  automated  for 
several platforms and thus is ideal for use in 
SNP  genotyping  but  its  high  cost  impedes 
widespread use. 
[46] Methods based on physical 
properties of DNA such as denaturing gradient 
gel  electrophoresis,  temperature  gradient  gel 
electrophoresis,  denaturing  HPLC,  single 
strand  conformation  polymorphism  and  high 
resolution  melt  analysis  can  also  be  used. 
However,  optimization  of  the  conditions  in 
order to standardize the experiments is rather 
difficult.  In  conclusion,  numerous  methods, 
both  computational  and  experimental  are 
available for SNP genotyping but choosing the 
right method poses a challenge to scientists as  
several  factors  need  to  be  taken  into 
consideration  such  as   accuracy,  reliability, 
cost effectiveness and ease of use. 
 
CONCLUSION 
 
Hundreds of SNPs and other genetic markers 
have been genotyped in several populations of 
autistic individuals. However, very few studies  
have been conducted on Indians. We propose 
that SNP genotyping be done on Indian autistic 
individuals.  This  data  can  find  applications  in 
diagnostics,  pharmacogenomics  and  gene 
therapy. Currently, no specific test is available 
to  diagnose  autism  and  clinicians  base  their 
diagnosis  on  behavior  evaluations  and 
questionnaires 
[48].  Knowing  the  genetic 
markers  would  thus  help  in  accurate,  rapid 
diagnosis in the future. 
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